This Government Contract opportunity from Department Of Defense was posted on June 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Doxycycline for Injection, USP – Pharmaceutical Supply and Delivery
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This contract involves the supply and delivery of sterile, injectable Doxycycline for Injection, USP, meeting United States Pharmacopeia (USP) standards. The product must adhere to military packaging specifications (MIL-STD-129) and comply with all applicable federal regulatory requirements. The contract is a subcontract issued by the Defense Logistics Agency, part of the Department of Defense, ensuring that the pharmaceutical product meets stringent quality and packaging standards for military use. The solicitation was posted on June 1, 2026, and responses are due by June 8, 2026. It falls under NAICS code 325412, which relates to pharmaceutical manufacturing. Specific details such as the place of performance and point of contact are not disclosed. The contract focuses on timely and compliant delivery of the injectable medication to support federal defense logistics operations.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
